Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies.
Blood. 2020 Jan 2;135(1):17-27. doi: 10.1182/blood.2019000017.
Blood. 2020.
PMID: 31697824
Free article.
Clinical Trial.